MKS (NASDAQ:MKSI) Price Target Raised to $380.00

Дата публикации: 10-08-2026 05:36:49

MKS (NASDAQ:MKSI – Free Report) had its price objective lifted by JPMorgan Chase & Co. from $365.00 to $380.00 in a research report report published on Friday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the scientific and technical instruments company’s stock. MKSI has been the topic of a number of […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Natera (NASDAQ:NTRA) Price Target Raised to $360.00	0	14.27	10-08-2026
2	Target (NYSE:TGT) Price Target Raised to $157.00	0	13.85	10-08-2026
3	Cencora (NYSE:COR) Price Target Raised to $390.00	0	11.9	10-08-2026
4	TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00	0	13.04	10-08-2026
5	CACI International (NYSE:CACI) Price Target Raised to $715.00	0	14.65	10-08-2026
6	Replimune Group (NASDAQ:REPL) Price Target Raised to $20.00	0	13.83	10-08-2026
7	Insight Enterprises (NASDAQ:NSIT) Price Target Raised to $160.00	0	14.65	10-08-2026
8	Doximity (NYSE:DOCS) Price Target Raised to $31.00	0	12.67	10-08-2026
9	Genpact (NYSE:G) Price Target Raised to $45.00	0	14.26	10-08-2026
10	PAR Technology (NYSE:PAR) Price Target Raised to $18.00	0	14.24	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 13.85. Источник: www.americanbankingnews.com.